Is BMJ Open a Good Journal? An Honest Assessment
Is BMJ Open a good journal for your research? A Manusights decision guide on fit, review model, transparency, and when BMJ Open is the right choice.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Journal fit
See whether this paper looks realistic for BMJ Open.
Run the Free Readiness Scan with BMJ Open as your target journal and see whether this paper looks like a realistic submission.
How to read BMJ Open as a target
This page should help you decide whether BMJ Open belongs on the shortlist, not just whether it sounds impressive.
Question | Quick read |
|---|---|
Best for | BMJ Open publishes medical research across clinical medicine, public health, and epidemiology without the. |
Editors prioritize | Methodological soundness over novelty |
Think twice if | Skipping reporting checklists |
Typical article types | Research, Protocol, Systematic Review |
Quick answer
BMJ Open is a credible medical journal if your work is methodologically solid, clinically relevant, and better served by a soundness-and-transparency model than by a prestige filter. It is especially useful for protocols, negative results, health services research, and careful observational work. It is the wrong target if you need the selectivity or brand signal of The BMJ or a top specialty title.
So you're wondering: is BMJ Open a good journal? The short answer is yes, but with specific conditions. BMJ Open occupies a particular niche in medical publishing that works brilliantly for some researchers and terribly for others. It's not about the journal's quality. It's about fit.
BMJ Open launched in 2011 as part of the BMJ Publishing Group's push into open-access publishing. Unlike its prestigious sibling BMJ (impact factor 30.3), BMJ Open doesn't filter for clinical significance or novelty. It publishes methodologically sound research across clinical medicine, public health, and epidemiology, period.
That approach attracts a lot of submissions because it fills a real gap in medicine: there are many worthwhile studies that deserve publication even if they are not flashy enough for the most selective journals. The papers that fail here usually do so on method, reporting, or scope fit rather than on a lack of novelty alone.
What BMJ Open Actually Publishes (And What It Doesn't)
BMJ Open publishes research that answers clear questions with appropriate methods. That's it. No novelty requirement. No "clinical significance" filter. No preference for positive results.
The journal accepts clinical trials, observational studies, systematic reviews, and study protocols. It also publishes negative results, which most selective journals won't touch. This makes it particularly valuable for researchers conducting pre-registered studies or replication attempts.
What does get desk-rejected? Case reports with fewer than three cases. Basic science without clear clinical relevance. Studies that don't follow established reporting guidelines (CONSORT, STROBE, PRISMA). Manuscripts where the research question isn't clearly stated in the first paragraph.
The scope covers anything that fits under "medical research." Clinical trials of new treatments. Epidemiological studies of disease patterns. Health services research on care delivery. Public health interventions. Health economics analyses. If you can make a reasonable argument that it matters for human health, BMJ Open will consider it.
But here's what separates BMJ Open from purely volume-driven journals: they actually enforce methodological standards. Underpowered studies get rejected. Studies with obvious confounding that isn't addressed get rejected. Analyses that don't match the stated objectives get rejected.
The editorial team includes practicing clinicians and academic researchers. They know the difference between a study that's methodologically sound and one that just looks impressive. This is why BMJ Open maintains credibility despite publishing 1,100+ papers annually.
One thing that surprises many authors: BMJ Open actively encourages protocol submissions. Publishing your study protocol before you collect data demonstrates transparency and helps prevent selective reporting. Most journals won't publish protocols because they don't generate citations. BMJ Open sees them as essential scientific infrastructure.
BMJ Open's Numbers: What They Actually Mean
BMJ Open's impact factor sits well below The BMJ and the top general medical journals, but that is not the right way to judge it. Its role is different: it is built to publish rigorous medical research that clears a soundness bar without pretending every accepted study has to be a career-defining discovery.
Compared with other broad open-access venues, BMJ Open's appeal is less about chasing the highest metric and more about editorial identity. It offers a medical audience, recognizable BMJ branding, and a transparent peer-review model that many authors find more trustworthy than higher-volume alternatives.
What do these numbers mean for your career? If you're a postdoc or early-career researcher, a BMJ Open publication carries real weight. It's indexed in PubMed and Web of Science. It counts for promotion committees. It demonstrates you can conduct rigorous research and navigate peer review.
If you're gunning for department chair positions at R1 universities, BMJ Open won't hurt you, but it won't help much either. You'll need some higher-impact publications to stand out.
The Open Peer Review Reality: What Authors Actually Experience
Here's where BMJ Open gets interesting: completely transparent peer review. When your paper gets accepted, the reviewer comments get published alongside the article. Reviewer names are included unless they specifically request anonymity.
This changes everything about the review process.
Reviewers tend to be more constructive and less nasty when they know their comments will be public. Authors get better feedback. Readers can evaluate the peer review quality for themselves. It's accountability in action.
But it also means your study gets more scrutiny, not less. Other researchers can see exactly what concerns the reviewers raised and how you addressed them. If your methods are questionable, that becomes part of the permanent record.
Some authors love this transparency. It demonstrates that their work survived rigorous peer review. It shows they addressed legitimate methodological concerns. It builds trust with readers who can see the full scientific conversation.
Other authors hate it. They worry about reviewer bias becoming visible. They don't want their methodological limitations discussed publicly. They prefer the traditional black-box peer review where only the final paper matters.
The practical impact: if you're confident in your methods and comfortable with transparency, BMJ Open's open peer review is an advantage. If your study has significant limitations or your methods are borderline, you might want to submit elsewhere first.
One unexpected benefit: the published peer review comments often get cited independently. Reviewers sometimes raise important theoretical or methodological points that other researchers find useful. This can increase your paper's visibility beyond the typical citation pattern.
BMJ Open vs The Competition: PLOS ONE, Scientific Reports, and BMC Series
The broad-scope medical journal landscape has several credible options, but they do not solve the same problem.
PLOS ONE is broader and more cross-disciplinary. If you want a journal that is unmistakably medical in audience and editorial framing, BMJ Open is usually the stronger fit.
Scientific Reports is broader still and can work for health research, but it does not offer the same specifically medical identity. If your goal is to reach clinicians, epidemiologists, or health-services researchers, BMJ Open tends to make more editorial sense.
The BMC series offers more specialty-specific paths. If your manuscript belongs squarely in public health, health-services research, or a more selective general-medicine lane, one of those titles may be a cleaner audience match.
Frontiers journals (Frontiers in Medicine, Frontiers in Public Health) use a different model entirely. They emphasize rapid publication and innovative review processes. Review times are faster, but the academic community has mixed opinions about Frontiers journals' long-term reputation.
Where does BMJ Open fit? It offers the best combination of medical focus, methodological rigor, and broad scope. You get specialized medical reviewers without the narrow audience of subspecialty journals. You get rigorous peer review without the novelty filter that kills solid science at selective journals.
The brand matters too. BMJ Open benefits from association with BMJ, one of the most respected names in medical publishing. That association carries weight with promotion committees, grant reviewers, and clinical colleagues in ways that purely commercial publishers don't match.
For systematic reviews and meta-analyses, BMJ Open is particularly strong. Their editorial team understands PRISMA guidelines and systematic review methodology. They publish high-quality systematic reviews that get well-cited. PLOS ONE and Scientific Reports are less focused on systematic review quality.
For protocol studies, BMJ Open is unmatched among broad-scope journals. They actively encourage protocol submissions and have streamlined the review process. This is partly because BMJ has a long history of publishing protocols in their main journal.
The 134-Day Review Timeline: What to Expect
BMJ Open is not usually the fastest option, but the timeline is fairly predictable. Expect an initial editorial screen, followed by standard external peer review for papers that survive the first pass.
Common desk-rejection reasons are straightforward: the manuscript does not really fit human-health research, the reporting is incomplete, the question is unclear, or the design does not support the claims being made.
For papers that go to review, expect 2-3 reviewers. The reviews are generally thorough and constructive. Reviewers focus on methodology, statistical analysis, and reporting quality rather than novelty or impact.
Revision requests are common because the journal takes reporting quality and methodological clarity seriously. Many accepted papers improve substantially in revision rather than sailing through unchanged.
The practical lesson is simple: if you need instant publication, BMJ Open may not be ideal. If you care more about transparent review and a recognizable medical venue than about speed alone, the tradeoff can be worth it.
Who Should Submit to BMJ Open (And Who Should Think Twice)
Submit to BMJ Open if you're conducting methodologically sound research that doesn't need to be groundbreaking. This includes protocol studies, replication attempts, negative results, pilot studies with clear limitations, systematic reviews of established topics, and health services research.
Submit if you're an early-career researcher building your publication record. BMJ Open provides legitimate peer-reviewed publications that count for career advancement without requiring breakthrough discoveries.
Submit if you're comfortable with transparency. The open peer review model works best for authors who view peer review as collaborative scientific dialogue rather than adversarial gatekeeping.
Submit if you're studying topics that selective journals might consider "uninteresting" but are methodologically important. Implementation science, validation studies, epidemiological surveys, and quality improvement projects often fit better at BMJ Open than specialty journals.
Think twice if you need maximum prestige for career advancement. While BMJ Open is respectable, it won't provide the career boost of high-impact specialty journals. If you're competing for department chair positions or major grants, you'll need some higher-impact publications too.
Think twice if your methods are questionable. BMJ Open's open peer review means methodological problems become part of the permanent record. If you're not confident your study design is sound, consider addressing those issues first before submitting anywhere.
Avoid BMJ Open if you're uncomfortable with public scrutiny of your work. The transparent peer review means other researchers can see what concerns reviewers raised and how you addressed them. Some authors prefer traditional closed peer review for this reason.
Avoid if you're trying to publish incremental work that doesn't advance knowledge meaningfully. While BMJ Open doesn't require novelty, they do expect research to serve some purpose. Studies that essentially repeat known findings without new insights rarely get accepted.
Consider your timeline too. BMJ Open's 134-day review process is thorough but not fast. If you need quick publication for thesis defense or grant deadlines, choosing the right journal strategy becomes more important.
Bottom Line: Is BMJ Open Worth It?
BMJ Open is worth it for most medical researchers, but you need to understand what you're getting.
You're getting legitimate peer review by medical experts who understand clinical research. You're getting open-access publication that maximizes readership. You're getting transparent peer review that builds trust with readers. You're getting association with the respected BMJ brand.
You're not getting high prestige or fast publication. You're not getting novelty-focused review that might boost your career. You're not getting the citation advantages that come with highly selective journals.
The question isn't whether BMJ Open is good - it's whether it's good for your specific research and career goals.
For protocol studies, systematic reviews of established topics, implementation science, and negative results, BMJ Open is often the best choice among broad-scope journals. For groundbreaking clinical research or studies that could change practice guidelines, you should probably aim higher first.
For early-career researchers, BMJ Open offers an excellent balance of rigor and accessibility. For senior researchers, it's a solid option when your research is methodologically strong but doesn't fit the novelty requirements of selective journals.
The open peer review model is either a major advantage or a significant concern, depending on your comfort with transparency. If you view peer review as collaborative scientific dialogue, you'll love it. If you prefer keeping the review process private, you won't.
Having trouble deciding if your research is ready for BMJ Open or any journal? ManuSights provides expert pre-submission reviews to identify potential issues before you submit, saving you months of review cycles and improving your acceptance chances.
- Comparative analysis of peer review timelines across open-access medical journals, 2023-2024 data
Jump to key sections
Sources
- 1. BMJ Open Editorial Policies and Submission Guidelines, updated January 2024
- 2. Journal Citation Reports 2024, Clarivate Analytics
- 3. BMJ Publishing Group Annual Report 2023, including submission and acceptance statistics
Final step
See whether this paper fits BMJ Open.
Run the Free Readiness Scan with BMJ Open as your target journal and get a manuscript-specific fit signal before you commit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Need deeper scientific feedback? See Expert Review Options
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
See whether this paper fits BMJ Open.
Anthropic Privacy Partner. Zero-retention manuscript processing.